Itraconazole is a broad-spectrum triazole antifungal agent used to treat a variety of systemic and superficial fungal infections, including histoplasmosis, blastomycosis, and various dermatophyte infections.… Read more













![Chemical structure of Trans-[2-Bromomethyl-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl]methyl Benzoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F61397-57-7-Trans-2-Bromomethyl-2-24-dichlorophenyl-13-dioxolan-4-ylmethyl-Benzoate.png&w=3840&q=75)
Itraconazole is a broad-spectrum triazole antifungal agent used to treat a variety of systemic and superficial fungal infections, including histoplasmosis, blastomycosis, and various dermatophyte infections. It functions by inhibiting lanosterol 14α-demethylase, a crucial enzyme in the ergosterol biosynthesis pathway, thereby disrupting fungal cell membrane integrity and causing cell death. The comprehensive range of associated reference standards, including pharmaceutical impurities, metabolites, and stable isotope labelled compounds, is essential for rigorous quality control and regulatory compliance in pharmaceutical laboratories. These materials are utilized in analytical testing to support impurity profiling, facilitate accurate method validation, and verify the potency and safety of drug products during stability studies. By providing precise benchmarks for identity and quantification, these high-quality compounds enable laboratories to ensure consistency and reliability throughout the pharmaceutical development and manufacturing process.